4
Changes in Ownership
Vivos Therapeutics, Inc. Filed Acc 0001493152-20-023466
Chief Executive Officer bought 500 shares at $8.50 ($4,250)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Huntsman Ronald Kirk Chief Executive Officer | 2020-12-11 | Purchase | +500 | $8.50 | $4,250 | 500 | D |
| Open-market purchases · 500 sh · avg $8.50 · $4,250 | |||||||
Loading xslF345X03/ownership.xml…